Innate Pharma SA Current Investments
Innate Pharma SA (IPHA) had Current Investments of EUR 6.22 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:CurrentInvestments · last filed 2026-04-01
- 2025-12-31: Current Investments 6.22M EUR.
- 2025-06-30: Current Investments 6.32M EUR.
- 2024-12-31: Current Investments 14.38M EUR.
- 2024-06-30: Current Investments 21.81M EUR; Current Investments as first filed 21.81M EUR.
| Period end | Current Investments | Current Investments as first filed |
|---|---|---|
| 2025-12-31 | 6.22M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 6.32M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 14.38M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 21.81M EUR 6-K · filed 2025-09-17 | 21.81M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 21.85M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 17.48M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 17.26M EUR 20-F · filed 2026-04-01 | |
| 2022-06-30 | 20.40M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 16.08M EUR 20-F · filed 2025-04-30 | |
| 2021-06-30 | 15.34M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 14.85M EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | 16.20M EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 15.98M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 15.22M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 16.74M EUR 20-F · filed 2020-04-24 |